CXC Chemokine Receptor 1 Predicts Postoperative Prognosis and Chemotherapeutic Benefits for TNM II and III Resectable Gastric Cancer Patients

Oncotarget - United States
doi 10.18632/oncotarget.12815
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

CXC Chemokine Receptor 4 (CXCR4; NPY3R); Chemokine CXC Motif Ligand 12 (CXCL12; SDF-1); CXCR7

Science-Business eXchange
2012English

CXC Chemokine Receptor 6 (CXCR6); Chemokine CXC Motif Ligand 16 (CXCL16)

Science-Business eXchange
2012English

CXC Chemokine Receptor 2 (CXCR2)

Science-Business eXchange
2008English

Chemokine Receptor 4 Expression Is Correlated With the Occurrence and Prognosis of Gastric Cancer

FEBS Open Bio
BiochemistryGeneticsMolecular Biology
2020English

IGF-1 Receptor and IGF Binding Protein-3 Might Predict Prognosis of Patients With Resectable Pancreatic Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

High CC Chemokine Receptor 7 Expression Improves Postoperative Prognosis of Lung Adenocarcinoma Patients

British Journal of Cancer
Cancer ResearchOncology
2013English

Overexpression of CD151 Predicts Prognosis in Patients With Resected Gastric Cancer

PLoS ONE
Multidisciplinary
2013English

Spontaneous and Ligand-Induced Trafficking of CXC-Chemokine Receptor 4

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer

Cancer immunology research
Cancer ResearchImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy